- Home
- LTRN vs UG Comparison
LTRN vs UG Comparison
Compare LTRN & UG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LTRN
- UG
- Stock Information
- Founded
- LTRN 2013
- UG 1942
- Country
- LTRN United States
- UG United States
- Employees
- LTRN N/A
- UG N/A
- Industry
- LTRN Biotechnology: Pharmaceutical Preparations
- UG Package Goods/Cosmetics
- Sector
- LTRN Health Care
- UG Consumer Discretionary
- Exchange
- LTRN Nasdaq
- UG Nasdaq
- Market Cap
- LTRN 36.0M
- UG 36.1M
- IPO Year
- LTRN 2020
- UG N/A
- Fundamental
- Price
- LTRN $4.10
- UG $8.18
- Analyst Decision
- LTRN Strong Buy
- UG
- Analyst Count
- LTRN 1
- UG 0
- Target Price
- LTRN $25.00
- UG N/A
- AVG Volume (30 Days)
- LTRN 105.4K
- UG 4.6K
- Earning Date
- LTRN 11-06-2025
- UG 11-07-2025
- Dividend Yield
- LTRN N/A
- UG 8.73%
- EPS Growth
- LTRN N/A
- UG N/A
- EPS
- LTRN N/A
- UG 0.56
- Revenue
- LTRN N/A
- UG $10,856,174.00
- Revenue This Year
- LTRN N/A
- UG N/A
- Revenue Next Year
- LTRN N/A
- UG N/A
- P/E Ratio
- LTRN N/A
- UG $14.28
- Revenue Growth
- LTRN N/A
- UG N/A
- 52 Week Low
- LTRN $2.55
- UG $7.73
- 52 Week High
- LTRN $6.12
- UG $16.25
- Technical
- Relative Strength Index (RSI)
- LTRN 48.41
- UG 48.66
- Support Level
- LTRN $3.74
- UG $7.80
- Resistance Level
- LTRN $4.26
- UG $8.50
- Average True Range (ATR)
- LTRN 0.31
- UG 0.28
- MACD
- LTRN -0.04
- UG -0.04
- Stochastic Oscillator
- LTRN 47.51
- UG 38.80
About LTRN Lantern Pharma Inc.
Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.
About UG United-Guardian Inc.
United-Guardian Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products. Its product portfolio includes Klensoft, Deselex, Renacidin, Lubrajel Fluid. The company's pharmaceutical products are sold to and distributed by full-line drug wholesalers throughout the United States. Its medical and specialty industrial products are sold directly by the company to the end-users of those products or, in some cases, to contract manufacturers used by some of those end users. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. It derives key revenue from the sales made in the U.S.